Related Experiment Video
Updated: Jan 5, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Effectiveness of Iron Therapy on Breath Holding Spells in the Children
Elham Bidabadi1, Sedigheh Poornabi Darzi1, Parham Mashouf1
1Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Insights
Iron deficiency anemia may contribute to Breath-Holding Spells (BHS) in children. Treating iron deficiency significantly reduced spell frequency, suggesting a crucial role for iron levels in BHS management.
Area of Science:
- Pediatric Neurology
- Hematology
Background:
- Breath-Holding Spells (BHS) pathophysiology remains unclear.
- The link between BHS and anemia requires further investigation, despite anecdotal evidence of iron supplementation efficacy.
Purpose of the Study:
- To investigate the potential relationship between iron levels and the occurrence of Breath-Holding Spells in children.
- To evaluate the effectiveness of iron supplementation in managing BHS.
Main Methods:
- A cohort of 42 children (6 months–2 years) diagnosed with BHS were enrolled.
- All participants received ferrous sulfate treatment (6 mg/kg/d, 3 times daily) regardless of baseline iron status.
- Treatment response was assessed by monitoring spell frequency.
Main Results:
- Iron deficiency anemia was present in 21.42% and depleted iron stores in 52.38% of cases.
- Children with simple spells had higher mean hemoglobin (Hb) levels than those with severe spells (P=0.008).
- Iron therapy led to a significant reduction in spell frequency (40.14 to 11.14 spells/month, P<0.0001), with 76.19% achieving complete spell control.
Conclusions:
- Iron deficiency anemia appears to play a significant role in the initiation and severity of Breath-Holding Spells.
- Iron supplementation is an effective treatment for reducing the frequency and improving the outcomes of BHS in affected children.
Objectives:
The pathophysiology and mechanism of Breath-Holding Spells (BHS) remain controversial, and the relationship between BHS and anemia has not been clarified, although iron supplementation appears to be effective in many patients. We aimed to assess the probable relation of iron level with initiation of these spells in children.
Materials & Methods:
Overall, 42 children with a diagnosis of BHS, aged between 6 months to 2 yr were enrolled during Mar 2015 to Dec 2016 at Rasht 17th Shahrivar Hospital, Rasht, northern Iran. Ferrous sulfate solution prescribed 6 mg/kg/d, 3 times daily, for all of cases, regardless of their iron levels, and the response to the treatment was evaluated.
Results:
Twenty-five patients were boys (59.52%). The mean age for all patients was 11.71±4.63 months. Positive family history detected in 33.33%; iron deficiency anemia in 21.42%, depletion of iron stores in 52.38%, and normal iron status in 26.19% of cases. Simple spells showed significantly higher mean of Hb in comparison with severe spells (P=0.008); also increased number of spells per month significantly decreased the mean of Hb (P=0.007). Mean frequency of spells was 40.14±47.08 before and 11.14±31.10 after iron therapy, per month (P<0.0001). Overall, 32 patients (76.19%) had complete control of spells, 7 patients (16.66%) partial, 2 cases (4.76%) weak, and 1 child (2.38%) no response after iron therapy.
Conclusion:
Iron deficiency anemia may have an important role in BHS, and treatment of anemia may decrease number of the spells.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Heart Failure VI: Adjunct Therapies
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

